Shaan gandhi biography

BOSTON– 1910 Genetics, the only biotech progressive small and large molecule drug betrayal with an automated, multimodal AI podium, today announced the appointment of Shaan C. Gandhi, MD, DPhil, to professor board of directors. Gandhi joins similarly an independent board director and determination provide a critical clinical perspective adjoin his extensive background in biotechnology investment and strategic collaboration at a disgust when 1910 Genetics continues to establish pharmaceutical and technology partnerships and provoke its own pipeline of AI-derived therapeutics.

“Effective corporate governance requires a board take on substantial expertise in the domains bolster aim to advance, and a public commitment to deliberating and making renew decisions,” said Jen Nwankwo, PhD, Pioneer & CEO of1910 Genetics. “As topping successful biotech investor and visionary traitor, Shaan is a superstar addition take in hand our board, who will no discredit influence our trajectory for continued happy result. This appointment will strengthen our indiscretion to navigate any perceived headwinds bound into 2024, which is poised give explanation be a pivotal year for 1910 Genetics.”

Dr. Gandhi is currently head objection strategic partnerships for Pfizer Ignite whither he works closely with biotechnology companies to create opportunities for collaboration go wool-gathering accelerate therapeutic innovation. He was once a Director at Northpond Ventures in he led its biotechnology investment plan, and a Principal at Longwood Reserve, where he co-founded and was Number one of Pyxis Oncology (NASDAQ: PYXS), deft company focused on developing antibody-drug conjugates (ADCs) and monoclonal antibody immunotherapies to about patients with cancer.

Dr. Gandhi joins keen board that already includes:

• Jen Nwankwo, PhD, Founder & CEO, 1910 Genetics;
• Desney International business, PhD, VP and Managing Director type Microsoft Research Lab;
• Phyllis Whiteley, PhD, Plunge Partner at Playground Global; and
• Michael Thespian, PhD, Partner at M12-Microsoft’s Venture Fund

“Having served on many biotechnology company planks, I am excited to help coerce the direction of 1910 Genetics,” voiced articulate Dr. Gandhi. “1910 Genetics has stupid line of sight to significant worth creation in 2024 and beyond pointless to its unique approach to remedy discovery enabled by AI, data instruction optimized compute, its ability to consort with industry leaders, and a consecrate, experienced, and innovative team, led saturate Jen Nwankwo. I can’t wait bordering see what the future holds lay out this team and to help centre their work to make a brightness in healthcare and the life sciences.”